Middle East Healthcare (4009.SR) Earnings Analysis
Middle East Healthcare (4009.SR) next reports earnings on 2026-08-03, consensus EPS 0.931 SAR. Last quarter (2026-05-03) it missed with EPS 0.28 SAR vs 0.798 SAR est (-64.9%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 16.67.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4009.SR next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 0.931 SAR |
| Revenue estimate | 0.84B |
4009.SR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-03 | 0.28 SAR | 0.798 SAR | -64.9% | Miss |
| 2025-11-02 | 0.4378 SAR | 0.768 SAR | -43% | Miss |
| 2025-03-02 | 1.16 SAR | 0.69 SAR | +68.1% | Beat |
| 2024-11-03 | 0.671 SAR | 0.57 SAR | +17.7% | Beat |
| 2024-08-04 | 0.665 SAR | n/a | n/a | n/a |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
4009.SR valuation and analyst view
| Trailing P/E | 16.67 |
|---|---|
| Trailing EPS | 1.824 SAR |
| Price / book | 1.47 |
| Dividend yield | 1.65% |
| Market cap | 2.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Middle East Healthcare (4009.SR)'s next earnings date?
Middle East Healthcare is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 0.931 SAR and revenue estimate of 0.84B.
Did 4009.SR beat earnings last quarter?
In its 2026-05-03 report, 4009.SR posted EPS of 0.28 SAR versus a 0.798 SAR estimate — a miss of 64.9%.
What is 4009.SR's earnings track record?
Over the last 4 reported quarters with consensus data, 4009.SR beat estimates 2 times (50%).
What is 4009.SR's current P/E ratio and EPS?
4009.SR trades at a trailing P/E of 16.67 on trailing EPS of 1.824353975551827 SAR.
What do analysts rate 4009.SR?
4009.SR has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.